Pooled Analysis Of Phase I Dose-Escalation And Dose Cohort Expansion Studies Of Imp4297, A Novel Parp Inhibitor, In Chinese And Australian Patients With Advanced Solid Tumors.

JOURNAL OF CLINICAL ONCOLOGY(2019)

引用 6|浏览62
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要